SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Hatshepsut

PatientHatshepsut
Date of birth1978-02-10
IdentifiersMRN HR-AC006-SYN; SSN (made up) 000-06-9440
Document date2026-06-30
AuthorAmunet Okafor-Harrington, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Ms. Hatshepsut is a 48-year-old woman with type 2 diabetes found eleven weeks ago, periodontitis, and knee osteoarthritis, who comes for the preventive visit booked at intake. The urinary symptoms settled within two days of nitrofurantoin, and she finished the five days; the culture grew Escherichia coli sensitive to it. She is ready to step up semaglutide to 0.5 mg today. Her extraction site has healed and scaling and root planing is booked with the dental team. Her periods have been irregular for a year, with occasional night sweats that do not trouble her. She has never had a mammogram or colorectal screening, and her last cervical screening was more than five years ago. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 48
CystitisResolved; culture-sensitive Escherichia coli
DiabetesMetformin and semaglutide 0.25 mg; stepping up to 0.5 mg today
MoodPHQ-2 0

Health risk assessment. Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Okafor-Harrington. [S]

DomainFinding
Self-rated healthGood, better than in the spring
PsychosocialDemanding work she enjoys; trusted advisers; feels safe at home
Substance useAUDIT-C 1; no drug use
TobaccoNever
Physical activityWalks about 100 minutes a week; knee exercises three times a week
NutritionSmaller evening meals since starting semaglutide; fewer dates and less sweet tea
SleepSeven hours; occasional night sweats
SafetyWears a seat belt; no firearm at home; screen for intimate partner violence negative
Sexual and reproductive healthNot sexually active at present; no pregnancy plans; periods irregular for a year
Activities of daily livingIndependent

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever; weight down 3 kg since intake, as intended
EyesNegativeNo change in vision; retinal photographs normal last month
Ears, nose, mouth, and throatNegativeExtraction site healed; no gum pain
CardiovascularNegativeNo chest pain or ankle swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalPositiveMild fullness after large meals; no vomiting, change in bowel habit or blood in the stool
GenitourinaryPositiveIrregular periods for a year; no urinary symptoms now
MusculoskeletalPositiveKnee pain on stairs, easier with exercises and the gel; no other bone or joint pain
IntegumentaryNegativeNo rash or changing moles
EndocrinePositiveOccasional night sweats; thirst and night urination gone
BreastNegativeNo lump, pain or nipple discharge
PsychiatricNegativeMood good; PHQ-2 0

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ibuprofen 400 mg oral tablet, one tablet by mouth every six hours as needed for dental pain, with food, for up to one weekOne tablet every six hours as needed, with food; no more than four a dayOral route2026-04-14 to 2026-04-22completedS
Acetaminophen 500 mg oral tablet, two tablets (1 g) by mouth every six hours as needed for dental pain, alternating with ibuprofen, no more than 3 g a day, for up to one weekTwo tablets every six hours as needed; no more than six a dayOral route2026-04-14 to 2026-04-22completedS
Metformin extended-release 500 mg tablet, one tablet with the evening meal for one week, then two tablets (1000 mg) with the evening mealOne tablet with the evening meal for a week, then twoOral route2026-04-14activeS
Diclofenac sodium 1% gel, 4 g to each painful knee up to four times a day as needed4 g to each knee up to four times a day as neededTopical route2026-04-14activeS
Chlorhexidine gluconate 0.12% oral rinse, 15 mL swished for 30 seconds and spat out twice daily for two weeks after the extraction15 mL rinse twice daily for two weeksOral route2026-04-15 to 2026-04-29completedS
Semaglutide 0.25 mg subcutaneous injection once weekly (starting dose, planned for four weeks)0.25 mg once weeklySubcutaneous route2026-05-26 to 2026-06-30completedS
Semaglutide 0.5 mg subcutaneous injection once weekly (maintenance dose for now)0.5 mg once weeklySubcutaneous route2026-06-30activeS
Atorvastatin 20 mg oral tablet, one tablet by mouth dailyOne tablet dailyOral route2026-05-26activeS
Nitrofurantoin monohydrate/macrocrystals 100 mg capsule, one capsule by mouth twice daily with food for five daysOne capsule twice daily with food for five daysOral route2026-06-23 to 2026-06-28completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-30Body height160cmS
2026-06-30Body weight90kgS
2026-06-30Body mass index (BMI) [Ratio]35.2kg/m2S
2026-06-30Systolic blood pressure120mm[Hg]S
2026-06-30Diastolic blood pressure78mm[Hg]S
2026-06-30Heart rate76/minS
2026-06-30Respiratory rate14/minS
2026-06-30Body temperature36.6CelS
2026-06-30Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-30Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-06-30Total score [AUDIT-C]1{score}S

Physical Exam

Vital signs recorded on 2026-06-30; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 90.0 kg, BMI 35.2; blood pressure 120/78
MouthExtraction socket healed; gums red with calculus, as before periodontal therapy
NeckThyroid normal; no lymph nodes
BreastsNo masses, skin change or axillary nodes
CardiovascularRegular rhythm; no murmur
AbdomenSoft and non-tender
PelvicSpeculum examination with her consent and a chaperone; normal cervix; HPV sample taken
MusculoskeletalCrepitus in both knees without effusion; no bone tenderness

Problems

ProblemClinical statusVerificationCodeProvenance
Painful swelling of the left lower jaw for four days, after a throbbing toothache for three weeks under a broken lower left molar; low-grade temperature, no trismus, no swelling of the floor of the mouth or neck; dental abscess suspectedresolvedconfirmed R68.84S — Synthetic presenting concern at the index visit, superseded by the dental diagnosis the next day. It echoes the dental disease reported on the mummy identified as hers (R, after the index date), without linking to it.
Acute periapical abscess of the lower left first molar (tooth 19), non-restorable, with a localized buccal vestibular swelling and no spread to fascial spaces; drained and extractedresolvedconfirmed K04.7S — Synthetic modern diagnosis; no historical claim is made.
Type 2 diabetes found on screening (hemoglobin A1c 7.6% with a random glucose of 212 mg/dL from the same sample), with thirst and waking at night to pass urine; normal kidney function and urine albuminactiveconfirmed E11.65S — Synthetic screening finding at intake; not linked to the disputed claim of diabetes on the mummy (R).
Obesity, class 2 (BMI 36.3), with type 2 diabetes and knee osteoarthritis; she wants to feel stronger and move more easilyactiveconfirmed E66.812S — Synthetic finding at intake, recorded in person-first language.
Primary osteoarthritis of both knees: pain on stairs and after standing, morning stiffness under 30 minutes, crepitus, no effusion; a clinical diagnosis without imagingactiveconfirmed M17.0S — Synthetic finding at intake; not linked to the osteoarthritis reported on the mummy (R).
Periodontitis, generalized, stage III, grade C (bone loss to the middle third of the roots, two molars lost earlier to gum disease, and A1c above 7% as a grade modifier)activeconfirmed K05.323S — Synthetic finding at the dental consultation.
Acute uncomplicated cystitis (dysuria and frequency for two days, urine dipstick positive for leukocyte esterase and nitrite, no fever or flank pain); urine culture grew Escherichia coli sensitive to nitrofurantoin; resolvedresolvedconfirmed N30.00S — Synthetic intercurrent illness; not a historical claim.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today120/78 mmHg
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 1
Tobacco useCompleted todayNever smoked
Intimate partner violence screeningCompleted todayNegative
Breast cancer screeningOrderedScreening mammography every two years from 40; never screened
Cervical cancer screeningCompleted todayPrimary HPV test today; last screening more than five years ago
Colorectal cancer screeningOrderedFecal immunochemical test kit given; colonoscopy if positive or if she prefers it
Diabetes complicationsUp to dateRetinal photographs and a comprehensive foot examination last month; urine albumin normal at intake
Lipid screening and statinUp to dateOn atorvastatin since last month; lipids at the next review
Bone density testingNot indicatedAge 48 without a risk factor; at 65 or sooner if one appears
HIV screeningCompleted todayOnce for adults 15 to 65; sent today
Hepatitis C screeningCompleted todayOnce for adults 18 to 79; sent today
Hepatitis B screeningCompleted todayOnce for all adults; sent today before the first vaccine dose
Pneumococcal vaccineCompleted todayPCV20, one dose, for diabetes
Tetanus, diphtheria, and pertussisCompleted todayTdap; no booster recorded within ten years
Hepatitis B vaccineCompleted todayDose 1 of 2 today, for an adult with diabetes under 60
Influenza vaccineDueIn the autumn
COVID-19 vaccineDueIn the autumn
Zoster vaccineNot indicatedBegins at 50

Immunizations given today: Pneumococcal conjugate vaccine, 20-valent (PCV20), single dose for an adult with diabetes; Tetanus, diphtheria, and acellular pertussis vaccine (Tdap); Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]

Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Breast Cancer: Screening (2024); Cervical Cancer: Screening (2018); Colorectal Cancer: Screening (2021); Adult Immunization Schedule by Age (2026)

Follow-up: Fourteen-week review with A1c, lipids and ALT and the screening results; second hepatitis B dose at a nurse visit four weeks from today. Results of HIV and hepatitis tests by phone. Next preventive visit in one year. Next scheduled visit 2026-07-21: fourteen-week review: A1c, lipids, weight, periodontal therapy, knees, and screening results. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment for any illness from which she could return to her work and her household, and would not want her life prolonged if she could no longer know the people around her. She named a health care agent, recorded in the confidential part of the chart and not named here. To be revisited yearly. [S]